POSB395 Annual Health Insurance Treatment Cost of Seropositive Rheumatoid Arthritis Based on Routinely Collected Financing Data

Abstract

Authors

D Elmer D Endrei T Csákvári L Kajos N Németh B Molics L Horváth I Boncz

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×